A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

Bibliographic Details
Main Authors: Halioua-Haubold, C, Jolly, J, Pinedo Villanueva, R, Brindley, D, MacLaren, R
Format: Conference item
Published: Association for Research in Vision and Ophthalmology (ARVO) 2018
_version_ 1826276493697744896
author Halioua-Haubold, C
Jolly, J
Pinedo Villanueva, R
Brindley, D
MacLaren, R
author_facet Halioua-Haubold, C
Jolly, J
Pinedo Villanueva, R
Brindley, D
MacLaren, R
author_sort Halioua-Haubold, C
collection OXFORD
description
first_indexed 2024-03-06T23:14:47Z
format Conference item
id oxford-uuid:66c18840-e2e2-4bde-8b54-1dc777197735
institution University of Oxford
last_indexed 2024-03-06T23:14:47Z
publishDate 2018
publisher Association for Research in Vision and Ophthalmology (ARVO)
record_format dspace
spelling oxford-uuid:66c18840-e2e2-4bde-8b54-1dc7771977352022-03-26T18:33:56ZA dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)Conference itemhttp://purl.org/coar/resource_type/c_c94fuuid:66c18840-e2e2-4bde-8b54-1dc777197735Symplectic Elements at OxfordAssociation for Research in Vision and Ophthalmology (ARVO)2018Halioua-Haubold, CJolly, JPinedo Villanueva, RBrindley, DMacLaren, R
spellingShingle Halioua-Haubold, C
Jolly, J
Pinedo Villanueva, R
Brindley, D
MacLaren, R
A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title_full A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title_fullStr A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title_full_unstemmed A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title_short A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
title_sort dual variable markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years qalys
work_keys_str_mv AT haliouahauboldc adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT jollyj adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT pinedovillanuevar adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT brindleyd adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT maclarenr adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT haliouahauboldc dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT jollyj dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT pinedovillanuevar dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT brindleyd dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys
AT maclarenr dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys